The Impact of Neurotransmitters on the Neurobiology of Neurodegenerative Diseases
Neurodegenerative diseases affect millions of people worldwide. Neurodegenerative diseases result from progressive damage to nerve cells in the brain or peripheral nervous system connections that are essential for cognition, coordination, strength, sensation, and mobility. Dysfunction of these brain...
Gespeichert in:
| Veröffentlicht in: | International journal of molecular sciences 2023-10, Vol.24 (20), p.15340 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 20 |
| container_start_page | 15340 |
| container_title | International journal of molecular sciences |
| container_volume | 24 |
| creator | Davis, Sarah E Cirincione, Abagail B Jimenez-Torres, Ana Catya Zhu, Jun |
| description | Neurodegenerative diseases affect millions of people worldwide. Neurodegenerative diseases result from progressive damage to nerve cells in the brain or peripheral nervous system connections that are essential for cognition, coordination, strength, sensation, and mobility. Dysfunction of these brain and nerve functions is associated with Alzheimer's disease, Parkinson's disease, Huntington's disease, Amyotrophic lateral sclerosis, and motor neuron disease. In addition to these, 50% of people living with HIV develop a spectrum of cognitive, motor, and/or mood problems collectively referred to as HIV-Associated Neurocognitive Disorders (HAND) despite the widespread use of a combination of antiretroviral therapies. Neuroinflammation and neurotransmitter systems have a pathological correlation and play a critical role in developing neurodegenerative diseases. Each of these diseases has a unique pattern of dysregulation of the neurotransmitter system, which has been attributed to different forms of cell-specific neuronal loss. In this review, we will focus on a discussion of the regulation of dopaminergic and cholinergic systems, which are more commonly disturbed in neurodegenerative disorders. Additionally, we will provide evidence for the hypothesis that disturbances in neurotransmission contribute to the neuronal loss observed in neurodegenerative disorders. Further, we will highlight the critical role of dopamine as a mediator of neuronal injury and loss in the context of NeuroHIV. This review will highlight the need to further investigate neurotransmission systems for their role in the etiology of neurodegenerative disorders. |
| doi_str_mv | 10.3390/ijms242015340 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10607327</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A771910669</galeid><sourcerecordid>A771910669</sourcerecordid><originalsourceid>FETCH-LOGICAL-c483t-f4dbe7b339e22156222dc78bb31c5688d33fbe5a0f4b129ea62e504e74e85be43</originalsourceid><addsrcrecordid>eNptkk1P3DAQhi0EKnTpkSuK1Esvof6Mk1OFoB9ICIQEZ8t2JotXib3YCRL_vk7ZbtkK-WDL88w7nteD0AnBZ4w1-KtbDYlyiolgHO-hI8IpLTGu5P6b8yH6mNIKY8qoaD6gQybrRmCKj9Dd_SMUV8Na27EIXXEDUwxj1D4NbhwhpiL4YszIn4BxoQ_Lly3YwhI8RD26ZyguXQKdIB2jg073CT5t9gV6-PH9_uJXeX378-ri_Lq0vGZj2fHWgDS5B6CUiIpS2lpZG8OIFVVdt4x1BoTGHTeENqArCgJzkBxqYYCzBfr2qruezACtBZ_f3at1dIOOLypop3Yj3j2qZXhWBFdYMiqzwpeNQgxPE6RRDS5Z6HvtIUxJ0bpmQhJZzcU-_4euwhR97m-msqmikc0_aql7UM53s5V2FlXnUpImV65m6uwdKq8WBmeDh87l-52E8jXBxpBShG7bJMFqHgK1MwSZP33rzJb---vsN79-rOs</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2882595979</pqid></control><display><type>article</type><title>The Impact of Neurotransmitters on the Neurobiology of Neurodegenerative Diseases</title><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Davis, Sarah E ; Cirincione, Abagail B ; Jimenez-Torres, Ana Catya ; Zhu, Jun</creator><creatorcontrib>Davis, Sarah E ; Cirincione, Abagail B ; Jimenez-Torres, Ana Catya ; Zhu, Jun</creatorcontrib><description>Neurodegenerative diseases affect millions of people worldwide. Neurodegenerative diseases result from progressive damage to nerve cells in the brain or peripheral nervous system connections that are essential for cognition, coordination, strength, sensation, and mobility. Dysfunction of these brain and nerve functions is associated with Alzheimer's disease, Parkinson's disease, Huntington's disease, Amyotrophic lateral sclerosis, and motor neuron disease. In addition to these, 50% of people living with HIV develop a spectrum of cognitive, motor, and/or mood problems collectively referred to as HIV-Associated Neurocognitive Disorders (HAND) despite the widespread use of a combination of antiretroviral therapies. Neuroinflammation and neurotransmitter systems have a pathological correlation and play a critical role in developing neurodegenerative diseases. Each of these diseases has a unique pattern of dysregulation of the neurotransmitter system, which has been attributed to different forms of cell-specific neuronal loss. In this review, we will focus on a discussion of the regulation of dopaminergic and cholinergic systems, which are more commonly disturbed in neurodegenerative disorders. Additionally, we will provide evidence for the hypothesis that disturbances in neurotransmission contribute to the neuronal loss observed in neurodegenerative disorders. Further, we will highlight the critical role of dopamine as a mediator of neuronal injury and loss in the context of NeuroHIV. This review will highlight the need to further investigate neurotransmission systems for their role in the etiology of neurodegenerative disorders.</description><identifier>ISSN: 1422-0067</identifier><identifier>ISSN: 1661-6596</identifier><identifier>EISSN: 1422-0067</identifier><identifier>DOI: 10.3390/ijms242015340</identifier><identifier>PMID: 37895020</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Alzheimer Disease - pathology ; Alzheimer's disease ; Amyotrophic lateral sclerosis ; Apoptosis ; Brain - pathology ; Brain damage ; Cocaine ; Development and progression ; Disease ; Dopamine ; Drug use ; Enzymes ; Epidemiology ; Highly active antiretroviral therapy ; HIV ; HIV Infections - pathology ; Human immunodeficiency virus ; Humans ; Huntington Disease - pathology ; Huntingtons disease ; Kinases ; Localization ; Metabolites ; Nervous system diseases ; Neurobiology ; Neurodegenerative Diseases - pathology ; Neurons ; Neurophysiology ; Neurosciences ; Neurotoxicity ; Phosphorylation ; Proteins ; Review ; Substance abuse treatment</subject><ispartof>International journal of molecular sciences, 2023-10, Vol.24 (20), p.15340</ispartof><rights>COPYRIGHT 2023 MDPI AG</rights><rights>2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2023 by the authors. 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c483t-f4dbe7b339e22156222dc78bb31c5688d33fbe5a0f4b129ea62e504e74e85be43</citedby><cites>FETCH-LOGICAL-c483t-f4dbe7b339e22156222dc78bb31c5688d33fbe5a0f4b129ea62e504e74e85be43</cites><orcidid>0000-0001-9653-5066 ; 0000-0003-0289-125X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10607327/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10607327/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37895020$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Davis, Sarah E</creatorcontrib><creatorcontrib>Cirincione, Abagail B</creatorcontrib><creatorcontrib>Jimenez-Torres, Ana Catya</creatorcontrib><creatorcontrib>Zhu, Jun</creatorcontrib><title>The Impact of Neurotransmitters on the Neurobiology of Neurodegenerative Diseases</title><title>International journal of molecular sciences</title><addtitle>Int J Mol Sci</addtitle><description>Neurodegenerative diseases affect millions of people worldwide. Neurodegenerative diseases result from progressive damage to nerve cells in the brain or peripheral nervous system connections that are essential for cognition, coordination, strength, sensation, and mobility. Dysfunction of these brain and nerve functions is associated with Alzheimer's disease, Parkinson's disease, Huntington's disease, Amyotrophic lateral sclerosis, and motor neuron disease. In addition to these, 50% of people living with HIV develop a spectrum of cognitive, motor, and/or mood problems collectively referred to as HIV-Associated Neurocognitive Disorders (HAND) despite the widespread use of a combination of antiretroviral therapies. Neuroinflammation and neurotransmitter systems have a pathological correlation and play a critical role in developing neurodegenerative diseases. Each of these diseases has a unique pattern of dysregulation of the neurotransmitter system, which has been attributed to different forms of cell-specific neuronal loss. In this review, we will focus on a discussion of the regulation of dopaminergic and cholinergic systems, which are more commonly disturbed in neurodegenerative disorders. Additionally, we will provide evidence for the hypothesis that disturbances in neurotransmission contribute to the neuronal loss observed in neurodegenerative disorders. Further, we will highlight the critical role of dopamine as a mediator of neuronal injury and loss in the context of NeuroHIV. This review will highlight the need to further investigate neurotransmission systems for their role in the etiology of neurodegenerative disorders.</description><subject>Alzheimer Disease - pathology</subject><subject>Alzheimer's disease</subject><subject>Amyotrophic lateral sclerosis</subject><subject>Apoptosis</subject><subject>Brain - pathology</subject><subject>Brain damage</subject><subject>Cocaine</subject><subject>Development and progression</subject><subject>Disease</subject><subject>Dopamine</subject><subject>Drug use</subject><subject>Enzymes</subject><subject>Epidemiology</subject><subject>Highly active antiretroviral therapy</subject><subject>HIV</subject><subject>HIV Infections - pathology</subject><subject>Human immunodeficiency virus</subject><subject>Humans</subject><subject>Huntington Disease - pathology</subject><subject>Huntingtons disease</subject><subject>Kinases</subject><subject>Localization</subject><subject>Metabolites</subject><subject>Nervous system diseases</subject><subject>Neurobiology</subject><subject>Neurodegenerative Diseases - pathology</subject><subject>Neurons</subject><subject>Neurophysiology</subject><subject>Neurosciences</subject><subject>Neurotoxicity</subject><subject>Phosphorylation</subject><subject>Proteins</subject><subject>Review</subject><subject>Substance abuse treatment</subject><issn>1422-0067</issn><issn>1661-6596</issn><issn>1422-0067</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNptkk1P3DAQhi0EKnTpkSuK1Esvof6Mk1OFoB9ICIQEZ8t2JotXib3YCRL_vk7ZbtkK-WDL88w7nteD0AnBZ4w1-KtbDYlyiolgHO-hI8IpLTGu5P6b8yH6mNIKY8qoaD6gQybrRmCKj9Dd_SMUV8Na27EIXXEDUwxj1D4NbhwhpiL4YszIn4BxoQ_Lly3YwhI8RD26ZyguXQKdIB2jg073CT5t9gV6-PH9_uJXeX378-ri_Lq0vGZj2fHWgDS5B6CUiIpS2lpZG8OIFVVdt4x1BoTGHTeENqArCgJzkBxqYYCzBfr2qruezACtBZ_f3at1dIOOLypop3Yj3j2qZXhWBFdYMiqzwpeNQgxPE6RRDS5Z6HvtIUxJ0bpmQhJZzcU-_4euwhR97m-msqmikc0_aql7UM53s5V2FlXnUpImV65m6uwdKq8WBmeDh87l-52E8jXBxpBShG7bJMFqHgK1MwSZP33rzJb---vsN79-rOs</recordid><startdate>20231019</startdate><enddate>20231019</enddate><creator>Davis, Sarah E</creator><creator>Cirincione, Abagail B</creator><creator>Jimenez-Torres, Ana Catya</creator><creator>Zhu, Jun</creator><general>MDPI AG</general><general>MDPI</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-9653-5066</orcidid><orcidid>https://orcid.org/0000-0003-0289-125X</orcidid></search><sort><creationdate>20231019</creationdate><title>The Impact of Neurotransmitters on the Neurobiology of Neurodegenerative Diseases</title><author>Davis, Sarah E ; Cirincione, Abagail B ; Jimenez-Torres, Ana Catya ; Zhu, Jun</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c483t-f4dbe7b339e22156222dc78bb31c5688d33fbe5a0f4b129ea62e504e74e85be43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Alzheimer Disease - pathology</topic><topic>Alzheimer's disease</topic><topic>Amyotrophic lateral sclerosis</topic><topic>Apoptosis</topic><topic>Brain - pathology</topic><topic>Brain damage</topic><topic>Cocaine</topic><topic>Development and progression</topic><topic>Disease</topic><topic>Dopamine</topic><topic>Drug use</topic><topic>Enzymes</topic><topic>Epidemiology</topic><topic>Highly active antiretroviral therapy</topic><topic>HIV</topic><topic>HIV Infections - pathology</topic><topic>Human immunodeficiency virus</topic><topic>Humans</topic><topic>Huntington Disease - pathology</topic><topic>Huntingtons disease</topic><topic>Kinases</topic><topic>Localization</topic><topic>Metabolites</topic><topic>Nervous system diseases</topic><topic>Neurobiology</topic><topic>Neurodegenerative Diseases - pathology</topic><topic>Neurons</topic><topic>Neurophysiology</topic><topic>Neurosciences</topic><topic>Neurotoxicity</topic><topic>Phosphorylation</topic><topic>Proteins</topic><topic>Review</topic><topic>Substance abuse treatment</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Davis, Sarah E</creatorcontrib><creatorcontrib>Cirincione, Abagail B</creatorcontrib><creatorcontrib>Jimenez-Torres, Ana Catya</creatorcontrib><creatorcontrib>Zhu, Jun</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>International journal of molecular sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Davis, Sarah E</au><au>Cirincione, Abagail B</au><au>Jimenez-Torres, Ana Catya</au><au>Zhu, Jun</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Impact of Neurotransmitters on the Neurobiology of Neurodegenerative Diseases</atitle><jtitle>International journal of molecular sciences</jtitle><addtitle>Int J Mol Sci</addtitle><date>2023-10-19</date><risdate>2023</risdate><volume>24</volume><issue>20</issue><spage>15340</spage><pages>15340-</pages><issn>1422-0067</issn><issn>1661-6596</issn><eissn>1422-0067</eissn><abstract>Neurodegenerative diseases affect millions of people worldwide. Neurodegenerative diseases result from progressive damage to nerve cells in the brain or peripheral nervous system connections that are essential for cognition, coordination, strength, sensation, and mobility. Dysfunction of these brain and nerve functions is associated with Alzheimer's disease, Parkinson's disease, Huntington's disease, Amyotrophic lateral sclerosis, and motor neuron disease. In addition to these, 50% of people living with HIV develop a spectrum of cognitive, motor, and/or mood problems collectively referred to as HIV-Associated Neurocognitive Disorders (HAND) despite the widespread use of a combination of antiretroviral therapies. Neuroinflammation and neurotransmitter systems have a pathological correlation and play a critical role in developing neurodegenerative diseases. Each of these diseases has a unique pattern of dysregulation of the neurotransmitter system, which has been attributed to different forms of cell-specific neuronal loss. In this review, we will focus on a discussion of the regulation of dopaminergic and cholinergic systems, which are more commonly disturbed in neurodegenerative disorders. Additionally, we will provide evidence for the hypothesis that disturbances in neurotransmission contribute to the neuronal loss observed in neurodegenerative disorders. Further, we will highlight the critical role of dopamine as a mediator of neuronal injury and loss in the context of NeuroHIV. This review will highlight the need to further investigate neurotransmission systems for their role in the etiology of neurodegenerative disorders.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>37895020</pmid><doi>10.3390/ijms242015340</doi><orcidid>https://orcid.org/0000-0001-9653-5066</orcidid><orcidid>https://orcid.org/0000-0003-0289-125X</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1422-0067 |
| ispartof | International journal of molecular sciences, 2023-10, Vol.24 (20), p.15340 |
| issn | 1422-0067 1661-6596 1422-0067 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10607327 |
| source | MDPI - Multidisciplinary Digital Publishing Institute; MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central |
| subjects | Alzheimer Disease - pathology Alzheimer's disease Amyotrophic lateral sclerosis Apoptosis Brain - pathology Brain damage Cocaine Development and progression Disease Dopamine Drug use Enzymes Epidemiology Highly active antiretroviral therapy HIV HIV Infections - pathology Human immunodeficiency virus Humans Huntington Disease - pathology Huntingtons disease Kinases Localization Metabolites Nervous system diseases Neurobiology Neurodegenerative Diseases - pathology Neurons Neurophysiology Neurosciences Neurotoxicity Phosphorylation Proteins Review Substance abuse treatment |
| title | The Impact of Neurotransmitters on the Neurobiology of Neurodegenerative Diseases |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T11%3A44%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Impact%20of%20Neurotransmitters%20on%20the%20Neurobiology%20of%20Neurodegenerative%20Diseases&rft.jtitle=International%20journal%20of%20molecular%20sciences&rft.au=Davis,%20Sarah%20E&rft.date=2023-10-19&rft.volume=24&rft.issue=20&rft.spage=15340&rft.pages=15340-&rft.issn=1422-0067&rft.eissn=1422-0067&rft_id=info:doi/10.3390/ijms242015340&rft_dat=%3Cgale_pubme%3EA771910669%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2882595979&rft_id=info:pmid/37895020&rft_galeid=A771910669&rfr_iscdi=true |